NEW YORK (AVAFIN) -- Baxter International options set a new 90-day record for the number of call contracts that exchanged
hands between the buyers and the sellers. Aggregate volume of puts was 6,445 and calls
was 22,734 equating to a 0.28 put/call ratio.
View Options Trading Activities
The skewed options ratio suggests that traders are re-balancing their portfolios in anticipation
of a price shift. Unusual volume activity directly reflects investor outlook and confirms that a
stock move is imminent.
Baxter International Inc is a healthcare Company, which develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic.
Biogen Idec and Novo Nordisk are taking aim at Baxter's Advate, and a less-frequent dosing schedule may be enough to convince physicians and patients to switch from Baxter's established brand.
Additionaly, Baxter temporarily shut down its Los Angeles plasma fractionation facility in 2012, putting further constraints on near-term supply of its plasma-derived products. Competitors could use this opportunity to work on eroding Baxter's strong reputation.
Shares of Baxter International edged down $1.33 (1.89%) to $68.90. The price of the stock ranged
between a low of $68.71 and $71.16 respectively. The trading volume of 4M is above
the 90 day average volume of 2M shares. BAX is trading below the 50
day moving average. The stock's 52 week low is $48.98 and 52 week high is $72.85. To date, the stock has lost -1.68% within the last week.
The stock has a P/E ratio of 16.80 and a dividend yield of 2.40%.
View Best Performing Stocks